Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam J Mead

Showing results (61-70 of 123) with videos related to

Pageof 13
Sort By:
British Journal of Haematology|June 26, 2014
Use of JAK inhibitors in the management of myelofibrosis: a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012John T Reilly, Mary Frances McMullin, Philip A Beer, et al.
British Journal of Haematology|July 14, 2024
Clinical utility of investigations in triple-negative thrombocytosis: A real-world, multicentre evaluation of UK practiceAnna L Godfrey, Nikolaos Sousos, Rebecca Frewin, et al.
Leukemia|January 12, 2023
Correction: Continuous Indexing of Fibrosis (CIF): improving the assessment and classification of MPN patientsHosuk Ryou, Korsuk Sirinukunwattana, Alan Aberdeen, et al.
British Journal of Haematology|December 4, 2025
Investigation and management of thrombocytosis without JAK2, CALR or MPL mutations: A British Society for Haematology GuidelineAnna L Godfrey, Alesia A Khan, Andrew McGregor, et al.
Cell Reports|September 15, 2021
Transitions in lineage specification and gene regulatory networks in hematopoietic stem/progenitor cells over human developmentAnindita Roy, Guanlin Wang, Deena Iskander, et al.
Leukemia|December 5, 2022
Continuous Indexing of Fibrosis (CIF): improving the assessment and classification of MPN patientsHosuk Ryou, Korsuk Sirinukunwattana, Alan Aberdeen, et al.
Haematologica|April 13, 2019
Cell-intrinsic depletion of Aml1-ETO-expressing pre-leukemic hematopoietic stem cells by K-Ras activating mutationCristina Di Genua, Ruggiero Norfo, Alba Rodriguez-Meira, et al.
Blood|August 5, 2011
Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferationShabnam Kharazi, Adam J Mead, Anna Mansour, et al.
Blood|March 29, 2013
Impact of isolated germline JAK2V617I mutation on human hematopoiesisAdam J Mead, Onima Chowdhury, Christian Pecquet, et al.
Ejhaem|February 26, 2024
Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosisStephen T Oh, Srdan Verstovsek, Vikas Gupta, et al.
Pageof 13

Showing results (61-70 of 123) with videos related to

Sort By:
Pageof 13
British Journal of Haematology|June 26, 2014
Use of JAK inhibitors in the management of myelofibrosis: a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012John T Reilly, Mary Frances McMullin, Philip A Beer, et al.
British Journal of Haematology|July 14, 2024
Clinical utility of investigations in triple-negative thrombocytosis: A real-world, multicentre evaluation of UK practiceAnna L Godfrey, Nikolaos Sousos, Rebecca Frewin, et al.
Leukemia|January 12, 2023
Correction: Continuous Indexing of Fibrosis (CIF): improving the assessment and classification of MPN patientsHosuk Ryou, Korsuk Sirinukunwattana, Alan Aberdeen, et al.
British Journal of Haematology|December 4, 2025
Investigation and management of thrombocytosis without JAK2, CALR or MPL mutations: A British Society for Haematology GuidelineAnna L Godfrey, Alesia A Khan, Andrew McGregor, et al.
Cell Reports|September 15, 2021
Transitions in lineage specification and gene regulatory networks in hematopoietic stem/progenitor cells over human developmentAnindita Roy, Guanlin Wang, Deena Iskander, et al.
Leukemia|December 5, 2022
Continuous Indexing of Fibrosis (CIF): improving the assessment and classification of MPN patientsHosuk Ryou, Korsuk Sirinukunwattana, Alan Aberdeen, et al.
Haematologica|April 13, 2019
Cell-intrinsic depletion of Aml1-ETO-expressing pre-leukemic hematopoietic stem cells by K-Ras activating mutationCristina Di Genua, Ruggiero Norfo, Alba Rodriguez-Meira, et al.
Blood|August 5, 2011
Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferationShabnam Kharazi, Adam J Mead, Anna Mansour, et al.
Blood|March 29, 2013
Impact of isolated germline JAK2V617I mutation on human hematopoiesisAdam J Mead, Onima Chowdhury, Christian Pecquet, et al.
Ejhaem|February 26, 2024
Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosisStephen T Oh, Srdan Verstovsek, Vikas Gupta, et al.
Pageof 13